WHO warns against overpriced vaccines, substandard coronavirus products

WHO warned of the danger of buying overpriced vaccines from intermediaries, reminding those countries should buy vaccines certified by the WHO and make sure to identify the origin of the product

WHO
ANI Europe
2 min read Last Updated : Jun 08 2021 | 6:47 AM IST

The World Health Organization (WHO) warned on Monday of the danger of buying overpriced vaccines from intermediaries, reminding those countries should buy vaccines certified by the WHO and make sure to identify the origin of the product.

"We have received concerns regarding other vaccines... with intermediates selling it (one vaccine) at a much higher price than what has been actually sold by the manufacturers," said Mariangela Batista Galvao Simao, WHO Assistant Director-General for Access to Medicines and Health Products, during a press conference.

The issue of the role of intermediates for buying vaccines was raised recently as a middleman, located in the United Arab Emirates, was caught selling Sputnik vaccines to Ghana and Pakistan at double the original price.

Simao said that countries should either buy directly from the manufacturer or "contact the manufacturer to make sure that the intermediate is legal."

"There is a lot of substandard and falsified COVID products being commercialized out there, so you need to know the provenance," she added.

Simao also said that it was important to vaccinate people with products "certified" by the WHO.

"The advice of the WHO is that the countries use vaccines that have received emergency listing," she said, referring to the Emergency Use Listing used by the organization to approve new vaccines.

So far, eight COVID-19 vaccines were approved by the WHO for emergency use, including two Chinese vaccines -- Sinopharm and Sinovac, both of which have been distributed in several countries across the world.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusWorld Health Organisation

First Published: Jun 08 2021 | 6:39 AM IST

Next Story